Biomedical Ethics & Trial Governance

Clinical Research Ethics, IRB Quorum Standards & Global Health Compliance

An independent reference repository documenting national research ethics committee (REC/IRB) governance, ICH-GCP E6(R3) trial oversight, and dual-use biosafety compliance.

Explore REC Structure & Pathway Tool · Ethical Risk & ICF Checklist

Physicians and clinical trial coordinators reviewing printed trial protocols and digital monitors in a modern hospital research center — Clinical research coordinators and ethics reviewers auditing multi-center study protocols.

Direct Regulatory Summary

National Research Ethics Committees (RECs) and Institutional Review Boards (IRBs) protect human research participants by enforcing independent protocol review, majority quorum rules (11 of 21 members under Liberia NREB statutory baselines), risk-benefit equipoise, and documented informed consent prior to clinical trial initiation under ICH-GCP E6(R3) and CIOMS 2016 standards.

Reference baseline: NIAID ClinRegs Liberia Profile & ICH Efficacy Guidelines.

Four Core Governance Pillars

Pillar 01 · Cited by NIH ClinRegs

REC Organization Structure & Review Pathways

Full breakdown of the 21-member multidisciplinary REC model, quorum thresholds, Full Board vs. Expedited criteria, and an interactive submission dossier checklist.

Open Pathway & Dossier Tool

Pillar 02 · Cited by GHS Index

Ethical Mandate & Dual-Use Biosafety

Human subjects protection charter, minimal-risk criteria, GHS Index Indicator 5.2 dual-use research oversight, and an interactive ICH-GCP E6(R3) risk checklist.

Open Risk & ICF Checklist

Pillar 03 · Global Standards

ICH-GCP E6(R3) & Multi-Regional Trials

Risk-Based Quality Management (RBQM), ICH E17 multi-regional trial design, Trial Master File (TMF) readiness, and 24-hour SUSAR safety reporting rules.

Read GCP Governance Guide

Pillar 04 · Sample & Outbreak Ethics

Biosecurity, MTAs & Outbreak Review

Material Transfer Agreements (MTAs), Nagoya Protocol benefit-sharing, pathogen genome governance, and accelerated PHEIC ethics review workflows.

Read Biosecurity Framework

Authoritative Reference Benchmarks

Comparison of Core Clinical Research Ethics & Regulatory Frameworks
Framework	Primary Scope	Review & Consent Mandate	Target Turnaround
Liberia NREB Baseline	National human-subjects trial oversight	21-member board; majority quorum (11)	28-42 days
ICH-GCP E6(R3)	Interventional drug & biologic trials	Risk-proportionate IRB review & eConsent	21-35 days
Declaration of Helsinki (2024)	Medical research involving human participants	Independent REC approval prior to enrollment	Pre-FPI gate
WHO / AVAREF Joint Review	Multi-country epidemic & vaccine trials	Harmonized national REC + NRA dossier	10-15 days (PHEIC)